13o3
London · Seed–Late Stage
Investment thesis
13o3 pursues impact-driven investment strategies with a commitment to wealth preservation and resilience. The firm combines personalized portfolio management for clients and partner companies with direct fund establishment that attracts institutional investors. Operating with strategic global reach while maintaining highly personalized investment approaches, 13o3 prioritizes sustainable growth and the ability to navigate complex market conditions and regulatory environments.
Source: firm website, verified Jul 21, 2026.
Frequently asked questions
- What stage does 13o3 invest at?
- 13o3 invests at the Seed, Late Stage stages.
- What sectors does 13o3 focus on?
- 13o3 focuses on Impact & Social Good.
- Where is 13o3 located?
- 13o3 is headquartered in London, GB.
- Does 13o3 lead rounds?
- 13o3 typically participates in rounds rather than leading them.
Similar investors
500 Global's Sustainable Growth practice designs and implements sovereign-aligned strategies that unlock resilient, inclusive, and sustainable economic growth across the Global Majority—Asia, Africa, Latin America, and the Middle East. The practice bridges public priorities and private capital through ecosystem development, blended finance, and localized innovation programs addressing health, agriculture, gender, climate, and education.
Octopus Ventures is a pan-European early-stage venture capital firm that invests from pre-seed through Series A and beyond, with pre-seed investments typically at £100k and later-stage investments starting at £1 million.
Partech is a global venture capital firm that supports founders across multiple continents through dedicated teams and specialized funds at various investment stages.
A firm that partners with the public sector to facilitate investment capital flows to communities across the country, leveraging federal and state programs like the New Markets Tax Credit and Low-income Housing Tax Credit.
Novo Holdings is a holding and investment company managing the assets of the Novo Nordisk Foundation, one of the world's largest enterprise foundations. The firm invests in life science companies across all development stages and manages a diversified portfolio including equities, bonds, real estate, infrastructure, and private equity.